Abstract: A stable pharmaceutical formulation according to the present disclosure contains: a recombinant fusion protein; a surfactant; a sugar or a derivative thereof; a buffer; and an isotonic agent. The stable pharmaceutical formulation according to the present disclosure has low viscosity while containing the recombinant fusion protein, may maintain excellent stability under long-term storage conditions, accelerated conditions and stress conditions, and may be administered intraocularly.

Abstract: The stable pharmaceutical formulation according to the present disclosure comprises (A) an antibody or antigen-binding fragment thereof that binds to an interleukin-6 receptor; (B) a surfactant; (C) stabilizers; and (D) a buffer. The stable pharmaceutical formulation according to the present disclosure has a low viscosity even when it contains an antibody, especially at a high concentration, and has excellent long-term storage stability based on excellent stability under accelerated and severe conditions, and may be administered intravenously or subcutaneously.

Abstract: A stable liquid pharmaceutical formulation according to the present invention includes an antibody or antigen-binding fragment thereof, a surfactant, a sugar or a sugar derivative, a buffer, and a stabilizer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity not only when antibody content is low but also when antibody content is high, and exhibits superior long-term storage stability based on superior stability observed under accelerated conditions and harsh conditions.

Abstract: A stable liquid pharmaceutical formulation according to the present invention includes an antibody or antigen-binding fragment thereof, a surfactant, a sugar or a sugar derivative, a buffer, and a stabilizer. The stable liquid pharmaceutical formulation according to the present invention has low viscosity not only when antibody content is low but also when antibody content is high, and exhibits superior long-term storage stability based on superior stability observed under accelerated conditions and harsh conditions.

Abstract: A wireless communication terminal and a battery pack for the same are disclosed. The wireless communication terminal includes a battery pack having one or more battery cells supplying power to the terminal, wherein the battery pack includes a protective circuit senses an high temperature or pressure condition of the one or more battery cells and disconnects battery power from the terminal circuitry.

Abstract: An apparatus and method for allowing a mobile device with a dead battery to be charged by another mobile device with a charged battery. The apparatus and method further provide for the prevention of damage to the batteries due to overcurrents that may occur due to battery voltage differences. Light emitting diodes are also provided to indicate the state of the charging device.

Abstract: An apparatus and method for allowing a mobile device with a dead battery to be charged by another mobile device with a charged battery. The apparatus and method further provide for the prevention of damage to the batteries due to overcurrents that may occur due to battery voltage differences. Light emitting diodes are also provided to indicate the state of the charging device.